Hyperbaric oxygen treatment: Results in seven... (2021 study) Skip to main content
Case Report Diving Hyperb Med 2021

Hyperbaric oxygen treatment: Results in seven patients with severe bacterial postoperative central nervous system infections and refractory mucormycosis

Valente Aguiar P, Carvalho B, Monteiro P, Linhares P, Camacho Ó, Vaz R, Diving Hyperb Med, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked back at the medical records of seven patients who had stubborn brain, spine or mucormycosis (a fungal infection) that had not cleared with surgery and antimicrobial drugs, and who were referred for hyperbaric oxygen treatment (HBOT) between 2010 and 2018.

What They Found

This retrospective case series of seven patients with refractory central nervous system infections reported infection resolution in six patients who received HBOT as an add-on to antimicrobial therapy. Four patients had infections after surgery and three had rhino-orbital-cerebral mucormycosis. Before HBOT, patients had an average of four operations and about five months of antimicrobial therapy. After HBOT, six patients had resolution without more operations. One patient with mucormycosis stopped HBOT after the third session because of intolerance. Three patients stopped antimicrobial therapy and four stayed on preventive treatment. The median follow-up was 20 months.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective review of only seven patients with no comparison group, so it cannot show that HBOT caused the infections to resolve, and one patient stopped treatment early because of intolerance.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 33761547
Year Published 2021
Journal Diving Hyperb Med
MeSH Terms Humans; Hyperbaric Oxygenation; Middle Aged; Mucormycosis; Oxygen Inhalation Therapy; Retrospective Studies; Treatment Outcome

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology